Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth,... Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma. 더 보기
- Gossamer to Present Preclinical Evidence of Synergistic Treatment Effect from Combination Seralutinib & Sotatercept in Models of PAH - Gossamer Bio, Inc. (Nasdaq: GOSS), a clinical-stage...
Gossamer Bio, Inc. (Nasdaq: GOSS), a clinical-stage biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary arterial hypertension...
Gossamer Bio, Inc. (Nasdaq: GOSS), a clinical-stage biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary arterial hypertension...
- $327 Million in Cash, Cash Equivalents & Marketable Securities, as of September 30, 2024 - Gossamer Bio, Inc. (Nasdaq: GOSS), a clinical-stage biopharmaceutical company focused on the...
Gossamer Bio, Inc. (Nasdaq: GOSS), a clinical-stage biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary arterial hypertension...
- Additional Phase 2 TORREY Open-Label Extension Data to be Presented in Vienna - Gossamer Bio, Inc. (Nasdaq: GOSS), a clinical-stage biopharmaceutical company focused on the development and...
기간 | 변동 | 변동 % | 시가 | 고가 | 저가 | 평균 일일 거래량 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.1106 | 12.436748004 | 0.8893 | 1 | 0.88 | 555069 | 0.93184039 | CS |
4 | 0.014 | 1.42002231464 | 0.9859 | 1.18 | 0.825 | 955377 | 0.99308066 | CS |
12 | 0.1299 | 14.9310344828 | 0.87 | 1.18 | 0.6617 | 1458218 | 0.85270974 | CS |
26 | 0.0402 | 4.18880900281 | 0.9597 | 1.18 | 0.6617 | 1102727 | 0.8832747 | CS |
52 | 0.1499 | 17.6352941176 | 0.85 | 1.6 | 0.4993 | 1497303 | 0.91156089 | CS |
156 | -8.2701 | -89.213592233 | 9.27 | 15.195 | 0.4525 | 2043456 | 2.82529607 | CS |
260 | -12.5001 | -92.5933333333 | 13.5 | 16.79 | 0.4525 | 1460859 | 4.16304912 | CS |
도움 및 지원받기: kr-support@advfn.com
ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관